Health service approaches to providing care for people who seek treatment for obesity: identifying challenges and ways forward

Introduction

Healthcare services in Australia fail to meet the needs of people seeking treatment for obesity. Obesity is underdiagnosed and undertreated amongst children^1,2 and adults³, taking, on average, almost 9 years for an adult with obesity to seek healthcare professional help for obesity management.³ Most weight management does not occur within a healthcare setting until it increases in severity and results in complications, whether metabolic, mechanical or psychosocial.

The Australian National obesity strategy 2022–23⁴, released in March 2022, highlights the importance of healthcare in addressing the high rates of obesity in Australia and acknowledges the urgent need for change. However, further clarity is needed regarding how this strategy will translate into practical changes at a policy and budgetary level and, more specifically, the impact on how health services and treatments will be funded and delivered.

Objectives and methods

This paper aims to identify challenges in Australia’s health service approaches to providing optimal care for people seeking treatment for obesity. Drawing on published evidence as well as personal perspectives and experiences, we reflect on the current state of the healthcare system for people seeking treatment for obesity. However, we also acknowledge that many people living with obesity require an approach that is non-medical and beyond weight loss. Additionally, given the large proportion of the population impacted by obesity, health service action should complement the community and social efforts addressing the broader social and commercial determinants of health.

As an authorship group, DR brings lived experience and research perspectives on self-directed weight loss. LB is a paediatrician with expertise in establishing and running a major paediatric weight management servic–, undertakes research on health services for paediatric and adult obesity and has worked on models of care for obesity management at the local and state level. MP is a clinical academic endocrinologist with over 14 years’ experience in the management of adults with severe obesity and bariatric surgery across multiple centres in the UK and Australia. CB is a general practitioner (GP) focusing on obesity management, has developed obesity training for primary care, and is founder of a group of general practice-based weight loss clinics for adults. MG is a public health physician currently undertaking a PhD focusing on preventing childhood obesity in healthcare settings. –

We discuss three key areas of challenge – complexity of care, service capability and capacity and out-of-pocket costs – and suggest eight areas for action to enable effective, acceptable and equitable care for people who seek treatment for obesity.

How can we address the health service challenges?

Our health service system, with its traditional ways of service delivery and funding models, is currently not geared to manage many noncommunicable diseases, including obesity. To address this challenge, a comprehensive response is required at all healthcare system levels. As a starting point, we propose eight areas of action to address the healthcare service challenges, as summarised in Figure 1.

Figure 1.

Actions required to address challenges in health services for people who seek treatment for obesity

1. Partner with people living with obesity, for example, via the Weight Issues Network (WIN).²¹ Leveraging lived experience perspectives in all stages of healthcare intervention, service design, and delivery helps to improve and develop approaches that reach the target population and effectively meet their needs to improve treatment outcomes.

2. Eliminate weight stigma. Anti-stigma policies and resources targeted at health providers and health services are urgently needed to enable respectful and supportive interactions between people living with obesity and their healthcare providers.⁹

3. Increase healthcare professional education, guidelines and resources. Health professionals receive inadequate education in obesity.⁵ Clinical obesity management should be integrated across the syllabus for undergraduate and postgraduate levels, along with addressing any entrenched weight bias. Examples include free e-learning and resources such as NSW Health’s Weight4KIDS²², Queensland’s Clinicians Hub²³ and the World Obesity Federation training program, SCOPE.²⁴ Health services subsidised by the Australian Government are outlined by the Medical Benefits Schedule (MBS). Access to specific MBS funding for obesity care could be linked to relevant training, similar to existing mental health provisions which provide a higher rebate for GPs with further training.

Updated national obesity treatment guidelines need to be developed and disseminated to help healthcare providers navigate the complexity of obesity treatment; the utility of living guidelines could be considered to keep pace with advances in management techniques.

4. Establish clear referral pathways and working partnerships. As the frontline of the Australian healthcare system, primary care should be enabled and empowered to manage people seeking treatment for obesity, in conjunction with adequately resourced secondary and tertiary care. Readily accessible and clear referral options in both community level and secondary/ tertiary healthcare services are needed, including funding for bariatric surgery as necessary. Links between primary, secondary and tertiary healthcare to promote continuity of care and support for patients with severe obesity can be built – for example, through formal partnerships between local GPs with a special interest in obesity management and hospital-based endocrinologists in obesity clinics.

5. Scale up services to meet the demand, including innovative solutions. More innovative approaches are needed to manage the scale of the issue. For example, self-directed weight loss and maintenance interventions via smartphone apps are scalable and can empower patients. Technology can be leveraged for delivering lifestyle advice, and health professionals can monitor self-reported data. In primary care, this may include the use of practice nurses and/or health coaches who may be funded through practice incentive programs or the MBS and shared medical appointments with General Practitioners to facilitate group programs.²⁵

6. Ensure flexible and accessible service delivery. More flexible telehealth options would enable service delivery, especially for people who cannot access services near where they live. Stronger linkages between health promotion, public health, clinical services and community services are needed to partner in obesity management, prevention and early intervention. Examples of existing partnerships include NSW Get Healthy telephone-based health coaching²⁶ and Go4Fun²⁷, a program for children aged 7–13 years.

7. Implement MBS changes to increase service provision. The MBS provides inadequate remuneration and/or options for relevant service provision considering the complexity of care and level of healthcare service required. For example, people with obesity who are managed under an MBS Chronic Disease Management plan can only access a total of five allied health visits per year in contrast to eating disorder plans or mental health plans that allow higher numbers of visits. People seeking treatment for obesity would greatly benefit from increased accessibility to allied health visits and higher reimbursement of allied health services. Shared medical appointments and online group programs can help meet the increased demand, yet the MBS funding model does not cater for group health delivery.

8. Seek opportunities for subsided PBS medications. Although the primary focus of obesity management is lifestyle intervention, some people require adjunctive pharmacotherapy. As new data for anti-obesity medications emerge, future opportunities for PBS subsidisation can facilitate broader and more equitable access to effective medications.

Conclusion

Our reflections on the management of obesity in the Australian health system highlight challenges that need to be addressed to provide optimal care for people seeking treatment for obesity. In partnership with patients, multilevel action is required to improve opportunities for access to adequately funded, well-integrated care. The proposed areas for action are a starting point to ensure equitable, effective and acceptable care for people seeking treatment for obesity.

Acknowledgements

MG is supported by a National Health and Medical Research Council (NHMRC) grant (GNT2005401). LB is supported by an NHMRC Leadership Fellowship (GNT2009035).

This paper is part of a special issue of the journal focusing on obesity prevention, which has been produced in partnership with the Health and Social Care Unit, School of Public Health and Preventive Medicine, Monash University, with support from VicHealth. LB and MG are guest editors for the special issue, but had no involvement in decisions about this paper.

Peer review and provenance

Externally peer reviewed, invited.

Author contributions

All authors contributed to the content, drafting and revision of the manuscript.

Competing interests

CB reports funding from Novo Nordisk, as a member of the semaglutide advisory board and for lectures on anti-obesity medication, and from iNova Pharmaceuticals for lectures on anti-obesity medications. She is a founder and director of Alevia Medical Weight Loss, a primary-care led obesity management service in Melbourne and Adelaide and founder and director of Valita Pty Ltd which produces obesity training and management software for GPs. DR is an unpaid chairperson and board member of the Weight Issues Network (WIN). WIN receives funding from Australian government grants and not-for-profit organisations including the Australian & New Zealand Obesity Society (ANZOS), Australian & New Zealand Metabolic and Obesity Surgery Society (ANZMOSS) and The Obesity Collective. MP has received funding from Johnson & Johnson for consultancy work, staff support from Counterweight UK and meeting expenses from iNova Pharmaceuticals. He reports speakers fees from Novo Nordisk, Lilly Australia, Takeda Australia and UCB Australia. LB has received funding from Novo Nordisk as a member of a study steering committee and speakers bureau.